These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15012621)

  • 1. A comparison between spironolactone and spironolactone plus finasteride in the treatment of hirsutism.
    Keleştimur F; Everest H; Unlühizarci K; Bayram F; Sahin Y
    Eur J Endocrinol; 2004 Mar; 150(3):351-4. PubMed ID: 15012621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial.
    Moghetti P; Tosi F; Tosti A; Negri C; Misciali C; Perrone F; Caputo M; Muggeo M; Castello R
    J Clin Endocrinol Metab; 2000 Jan; 85(1):89-94. PubMed ID: 10634370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of finasteride versus spironolactone in the treatment of idiopathic hirsutism.
    Erenus M; Yücelten D; Durmuşoğlu F; Gürbüz O
    Fertil Steril; 1997 Dec; 68(6):1000-3. PubMed ID: 9418687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.
    Sahin Y; Dilber S; Keleştimur F
    Fertil Steril; 2001 Mar; 75(3):496-500. PubMed ID: 11239530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome.
    Diri H; Karaburgu S; Acmaz B; Unluhizarci K; Tanriverdi F; Karaca Z; Kelestimur F
    Gynecol Endocrinol; 2016; 32(1):42-5. PubMed ID: 26370923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Finasteride treatment for one year in 35 hirsute patients.
    Bayram F; Müderris II; Sahin Y; Keleştimur F
    Exp Clin Endocrinol Diabetes; 1999; 107(3):195-7. PubMed ID: 10376445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism.
    Lumachi F; Rondinone R
    Fertil Steril; 2003 Apr; 79(4):942-6. PubMed ID: 12749435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of a gonadotropin-releasing hormone agonist and finasteride on idiopathic hirsutism.
    Bayhan G; Bahçeci M; Demirkol T; Ertem M; Yalinkaya A; Erden AC
    Clin Exp Obstet Gynecol; 2000; 27(3-4):203-6. PubMed ID: 11214952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of high-dose finasteride (5 mg/day) versus low-dose finasteride (2.5 mg/day) in the treatment of hirsutism.
    Bayram F; Müderris II; Güven M; Keleştimur F
    Eur J Endocrinol; 2002 Oct; 147(4):467-71. PubMed ID: 12370107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism.
    Lakryc EM; Motta EL; Soares JM; Haidar MA; de Lima GR; Baracat EC
    Gynecol Endocrinol; 2003 Feb; 17(1):57-63. PubMed ID: 12724020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
    Erenus M; Yücelten D; Gürbüz O; Durmuşoğlu F; Pekin S
    Fertil Steril; 1996 Aug; 66(2):216-9. PubMed ID: 8690104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome.
    Falsetti L; De Fusco D; Eleftheriou G; Rosina B
    Gynecol Endocrinol; 1997 Aug; 11(4):251-7. PubMed ID: 9272421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.
    Wong IL; Morris RS; Chang L; Spahn MA; Stanczyk FZ; Lobo RA
    J Clin Endocrinol Metab; 1995 Jan; 80(1):233-8. PubMed ID: 7829618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism.
    Erenus M; Gürbüz O; Durmuşoğlu F; Demirçay Z; Pekin S
    Fertil Steril; 1994 Apr; 61(4):613-6. PubMed ID: 8150100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of long-term treatment with the 5 alpha-reductase inhibitor finasteride in idiopathic hirsutism: clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up.
    Castello R; Tosi F; Perrone F; Negri C; Muggeo M; Moghetti P
    Fertil Steril; 1996 Nov; 66(5):734-40. PubMed ID: 8893676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism.
    Sahin Y; Bayram F; Keleştimur F; Müderris I
    J Endocrinol Invest; 1998 Jun; 21(6):348-52. PubMed ID: 9699125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Farquhar C; Lee O; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2003; (4):CD000194. PubMed ID: 14583916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone and spironolactone in the treatment of non-tumorous hyperandrogenism.
    Prezelj J; Kocijancic A; Andolsek L
    Gynecol Endocrinol; 1989 Dec; 3(4):281-8. PubMed ID: 2516705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spironolactone as a single agent for long-term therapy of hirsute patients.
    Spritzer PM; Lisboa KO; Mattiello S; Lhullier F
    Clin Endocrinol (Oxf); 2000 May; 52(5):587-94. PubMed ID: 10792338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, randomized trial comparing flutamide (250 mg/d) and finasteride (5 mg/d) in the treatment of hirsutism.
    Müderris II; Bayram F; Güven M
    Fertil Steril; 2000 May; 73(5):984-7. PubMed ID: 10785225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.